Compositions and methods for inducing protective immunity against human immunodeficiency virus infection
US11207400B2 · kind B2 · utility
0Cited by
14References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 4, 2019 |
| Grant date | Dec 28, 2021 |
| Priority date | — |
| Expiry date | Jan 23, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions, vaccines and methods for inducing an immunity, including a protective immunity, against Human Immunodeficiency Virus (HIV) infection are described. Heterologous vaccine combinations of one or more adenovirus 26 vectors using for priming immunization and an isolated HIV antigenic polypeptide in combination with one or more MVA vectors for boosting immunization induced strong protective immunity against infections by one or multiple clades of HIV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.